#1 Clinical Trials Search in Europe

Itraconazole

Itraconazole is an antifungal medication that has been the subject of several clinical trials exploring new formulations and applications. These studies aim to improve its effectiveness, bioavailability, and tolerability in treating various fungal infections. This article summarizes key findings from recent clinical trials investigating different forms of itraconazole and their potential benefits for patients.

Table of Contents

What is Itraconazole?

Itraconazole is an antifungal medication used to treat various fungal infections. It’s known by several brand names, including Sporanox[1] and Tolsura[2]. Itraconazole belongs to a class of drugs called azole antifungals, which work by preventing the growth of fungi that cause infections.

Uses of Itraconazole

Itraconazole is prescribed for several conditions:

  • Fungal infections: It’s used to treat various types of fungal infections, including those affecting the lungs, skin, nails, and other parts of the body[3].
  • Chronic Cavitary Pulmonary Aspergillosis (CCPA): This is a serious lung infection caused by a fungus called Aspergillus. Itraconazole has shown potential in treating this condition[3].
  • Prophylaxis in transplant patients: Itraconazole is sometimes used to prevent fungal infections in patients who have undergone lung transplants[2].

How Itraconazole Works

Itraconazole works by interfering with the formation of the fungal cell membrane. Specifically, it inhibits an enzyme called CYP3A4, which is crucial for the fungi to produce ergosterol, a key component of their cell membranes. Without proper cell membranes, the fungi cannot grow and spread, effectively treating the infection[4].

Forms and Administration

Itraconazole comes in several forms:

  • Oral capsules: These are typically taken with food to improve absorption[1].
  • Oral solution: This liquid form is often used when higher doses are needed or for patients who have difficulty swallowing capsules[4].
  • Tablets: Some newer formulations come in tablet form[5].

The dosage and duration of treatment can vary depending on the type and severity of the infection, as well as other individual factors. It’s crucial to follow your doctor’s instructions carefully when taking itraconazole.

Interactions with Other Medications

Itraconazole can interact with many other medications. It’s particularly important to note that:

  • Itraconazole is a strong inhibitor of CYP3A4, an enzyme involved in the metabolism of many drugs. This means it can increase the levels of other medications in your body, potentially leading to increased side effects[6].
  • Conversely, some medications can affect the levels of itraconazole in your body. For example, drugs that increase stomach acid (like antacids) can decrease the absorption of itraconazole[1].

Always inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements, before starting itraconazole treatment.

Side Effects and Safety

Like all medications, itraconazole can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • Rash

More serious side effects, though rare, can include liver problems and heart failure. Your doctor will monitor you for these potential complications[7].

Ongoing Research

Researchers continue to study itraconazole to better understand its effects and potential uses. Current areas of investigation include:

  • Drug interactions: Studies are examining how itraconazole interacts with other medications to ensure safe and effective use[8][9].
  • New formulations: Researchers are developing and testing new forms of itraconazole that may offer improved absorption or fewer side effects[2].
  • Use in specific patient populations: Studies are investigating the use of itraconazole in particular groups, such as older adults or those with certain medical conditions[5].

These ongoing studies aim to improve our understanding of itraconazole and optimize its use in treating fungal infections.

Aspect Details
New Formulations SUBA-itraconazole, Lozanoc, Tolsura
Conditions Studied Onychomycosis, Coccidioidomycosis, Fungal prophylaxis in transplant patients
Administration Methods Oral capsules, Intravenous infusion, Nasal irrigation
Key Outcomes Measured Plasma drug levels, Clinical cure rates, Mycological cure rates, Safety and tolerability
Potential Advantages Improved bioavailability, Reduced food effect, Better absorption
Patient Populations Immunocompromised patients, Lung transplant recipients, Patients with chronic fungal infections

FAQ

  • What is SUBA-itraconazole and how does it differ from conventional itraconazole? SUBA-itraconazole is a 'Super Bioavailability' formulation of itraconazole that offers improved absorption and pharmacokinetics compared to conventional itraconazole. It doesn't require food or stomach acidity for absorption, potentially making it more effective and convenient for patients.
  • What are some conditions being studied for treatment with itraconazole? Clinical trials are exploring the use of itraconazole for various fungal infections, including coccidioidomycosis (Valley Fever), onychomycosis (fungal nail infections), and as prophylaxis in immunocompromised patients such as those who have undergone lung transplants.
  • How is itraconazole being studied for use in lung transplant patients? A clinical trial is evaluating Tolsura (a brand of SUBA-itraconazole) as prophylaxis after lung transplantation. The study aims to determine the pharmacokinetics, safety, and effectiveness of Tolsura in preventing fungal infections in these high-risk patients.
  • What are researchers looking at regarding itraconazole levels in the body? Several studies are examining the plasma levels of itraconazole and its active metabolite, hydroxyitraconazole. Researchers are interested in how different formulations affect drug concentrations in the body and how this relates to treatment effectiveness and safety.
  • Are there any new ways of administering itraconazole being studied? Yes, one study is investigating the use of itraconazole as a nasal irrigation solution for patients with chronic rhinosinusitis. This topical application aims to achieve high local concentrations of the drug in the nasal passages while minimizing systemic exposure.

Ongoing Clinical Trials on Itraconazole

  • A study to test the safety and effects of TLN-372 alone and with other cancer drugs in patients with advanced solid tumors with KRAS gene changes

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of Itraconazole with Radiotherapy and Temozolomide for Patients with Newly Diagnosed Glioblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on the Effectiveness of Albaconazole and Fluconazole for Treating Acute Vaginal Yeast Infections in Women

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Poland Spain

Glossary

  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. PK studies help determine the best dosing and administration methods for medications.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect. Higher bioavailability generally means more of the drug is available to work in the body.
  • Prophylaxis: Preventive treatment to stop a disease from occurring. In the context of these studies, it refers to using itraconazole to prevent fungal infections in high-risk patients.
  • Onychomycosis: A fungal infection of the nails, typically causing thickening, discoloration, and separation of the nail from the nail bed.
  • Coccidioidomycosis: Also known as Valley Fever, this is a fungal infection caused by inhaling spores of certain fungi found in soil. It primarily affects the lungs but can spread to other parts of the body.
  • Neutropenia: A condition characterized by an abnormally low number of neutrophils (a type of white blood cell) in the blood, which increases the risk of infections.
  • Defervescence: The reduction or disappearance of fever, often used as a measure of treatment effectiveness in infectious diseases.
  • Therapeutic Cure: In clinical trials, this often refers to the complete resolution of symptoms and elimination of the infection, as confirmed by clinical assessment and laboratory tests.
  • Mycological Cure: The elimination of the fungal organism from the infected site, as confirmed by laboratory tests such as cultures or microscopic examination.
  • Steady-state: A condition where the overall intake of a drug is in dynamic equilibrium with its elimination, typically reached after multiple doses of medication.

References

  1. https://clinicaltrials.gov/study/NCT02621905
  2. https://clinicaltrials.gov/study/NCT04652050
  3. https://clinicaltrials.gov/study/NCT01259336
  4. https://clinicaltrials.gov/study/NCT03821493
  5. https://clinicaltrials.gov/study/NCT06706869
  6. https://clinicaltrials.gov/study/NCT04090047
  7. https://clinicaltrials.gov/study/NCT04962022
  8. https://clinicaltrials.gov/study/NCT05538312
  9. https://clinicaltrials.gov/study/NCT05745701